Clinical Validation of Nutritional Supplements("Ketogenic Plus") Developed for Pancreaticobiliary Cancer Patients

Pancreaticobiliary Cancer Clinical Trial

Official title:
Clinical Validation of Nutritional Supplements("Ketogenic Plus") Developed for Pancreaticobiliary Cancer Patients

Status Recruiting

Clinical Trial Summary

Decreased bowel function and loss of appetite in patients who underwent pancreaticobiliary surgery contribute impaired nutritional status in postoperative period. It can also affect perioperative and oncologic outcomes negatively. Therefore it is important to improve nutritional status in postoperative period by supply tailor-made optimal diets. The investigators have developed customized postoperative diets and products for pancreaticobiliary cancer patients. This time, newly developed ketogenic drink contain beefsteak mint.

The investigators expect that nutritional supplement for pancreaticobiliary patients will increase the food intake rate and contribute a improvement of perioperative outcomes and even oncologic outcomes.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Pancreaticobiliary Cancer

Clinical Trial Details

NCT number	NCT03510429
Study type	Interventional
Source	Yonsei University
Contact
Status	Recruiting
Phase	N/A
Start date	April 12, 2018
Completion date	December 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03294096` - Clinical Validation of Nutritional Supplements Developed for Pancreaticobiliary Cancer Patients	N/A
Completed	`NCT02964806` - Development and Clinical Validation of Ketogen-based Therapeutic Diet for Pancreaticobiliary Cancer Patients	N/A
Not yet recruiting	`NCT05171361` - Pancreaticogastrostomy Versus Pancreaticojejunostomy With Dunking Technique After Pancreaticodudenectomy: A Prospective Randomized Comparative Study